Federal Trade Commission

Six States Join FTC Lawsuit to Block Amgen-Horizon

Six US states – New York, California, Illinois, Wisconsin, Minnesota and Washington – have joined the Federal Trade Commission's lawsuit to block Amgen's proposed nearly $28 billion acquisition of Horizon Therapeutics.

US FTC Wants Court to Hold “Pharma Bro” in Contempt

The Federal Trade Commission (FTC) has asked a US federal judge to hold “pharma bro” Martin Shkreli in contempt for forming another drug company that it said violates a January 2022 court order that banned him from working in the pharmaceutical industry

FTC Blocks Evonik Takeover of Peroxychem

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

Watson Gets US Approval to Buy Actavis

FTC Takes "Pay for Delay" Drug Case to U.S. Supreme Court

U.S. Finds No Wrongdoing in Yasmin Patent Settlement

US FTC Loses Bid to Block Pay-for-delay Drug Deals